Research programme: cytomegalovirus vaccine - CAP-CMVAlternative Names: CAP-CMV-001
Latest Information Update: 13 Jan 2014
At a glance
- Originator CAP-CMV
- Class Cytomegalovirus vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cytomegalovirus infections
Most Recent Events
- 09 Jan 2014 Preclinical trials in Cytomegalovirus infections (prevention in patients undergoing solid organ transplantation) in Germany (Parenteral)